(lp0
S'MediciNova Inc.  Moves Lower on Volume Spike for March 22 Equities.com - 9 hours ago MediciNova Inc.  traded on unusually high volume on Mar. 22, as the stock lost 0.17% to close at $5.80. On the day, MediciNova Inc. saw 57,460 shares trade hands on 399 trades. Considering that the stock averages only a daily volume of 33,493&nbsp;...'
p1
aS'Shares in Focus: MediciNova Inc  Baxter Review - 9 hours ago Investors and Traders using technical analysis to study stocks may be looking at the ATR or Average True Range. Presently, MediciNova Inc  has a 14-day ATR of 0.22. The Average True Range is an investor tool used to gauge stock volatility.'
p2
aS'5.97 MarketWatch - Apr 14, 2011 MediciNova Inc. Watchlist CreateMNOVAlert. After Hours. Last Updated: Mar 20, 2017 5:38 p.m.. $ 5.97. 0.00 0.00%.'
p3
aS'MediciNova Inc. MNOV  Wall Street Journal - Feb 11, 2011 News MediciNova Inc.MNOV. Significant News Only. 02/27/17; Press Release. MediciNova Announces MN-166  Glioblastoma Abstract Selected for Presentation at the 5th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies&nbsp;...'
p4
aS"Trading Options During Earnings in MediciNova Inc  CML News - Mar 21, 2017 We're going to examine buying and selling out of the money strangles in MediciNova Inc and find out once and for all what the winning trades have been during earnings releases."
p5
aS'MediciNova Inc.  Soars 5.74% on February 27 Equities.com - Feb 27, 2017 MediciNova Inc.  had a good day on the market for Monday February 27 as shares jumped 5.74% to close at $6.45. About 58,763 shares traded hands on 511 trades for the day, compared with an average daily volume of 72,676 shares out of a total&nbsp;...'
p6
aS'Stock Focus: Checking the Chart on Shares of MediciNova, Inc.  SKV News - 11 hours ago Checking the Value Composite score for MediciNova, Inc. , we see that the company has a rank of 78. This falls on a scale from 0 to 100 where a lower score indicated an undervalued company and a higher score would indicate an&nbsp;...'
p7
aS'MediciNova Gets Fast Tracked Into Thick Of NASH Race Seeking Alpha - Apr 16, 2015 Today, MediciNova  announced that it has received Fast Track designation from the U.S. Food and Drug Administration  for tipelukast  for the treatment of NASH with fibrosis.Tokyo Stock Exchange Announces New Rule Affecting Trading of MediciNova Stock ... - GlobeNewswire '
p8
aS'MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN ... GlobeNewswire  - Jul 24, 2016 LA JOLLA, Calif., July 24, 2016  -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market  and the JASDAQ Market of the Tokyo Stock Exchange , today announced&nbsp;...'
p9
aS"MediciNova's Ibudilast And The Phase IIb Trial Offer Steady Outlook Seeking Alpha - Jan 18, 2016 Recent news surrounding Medicinova's  progress has concerned its drug MN-166, or ibudilast, and its treatment of ALS, commonly known as Lou Gehrig's disease."
p10
a.